Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Poison control center reference in OTC labeling should be retained -- NDAC member.

This article was originally published in The Rose Sheet

Executive Summary

POISON CONTROL CENTERS REFERENCE ON OTC LABELING RECOMMENDED by FDA Nonprescription Drugs Advisory Committee member Cage Johnson, MD, University of Southern California, as an item that should be retained in FDA's Feb. 27 proposed OTC drug label reform regulation. Speaking at NDAC's July 14 meeting in Bethesda, Md, Johnson said he "would strongly support the inclusion of `Poison Control Center' as a source of assistance" on OTC labels "rather than the somewhat nebulous `get medical help'" message suggested in the agency's proposed rule ("The Rose Sheet" March 3, pp. 11-13). The Poison Control Center is "the source of the most topical, most accurate information in cases of accidental overdose," Johnson maintained.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts